These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 16876765)

  • 1. Recruitment of an interferon molecular signaling complex to the mitochondrial membrane: disruption by hepatitis C virus NS3-4A protease.
    Hiscott J; Lacoste J; Lin R
    Biochem Pharmacol; 2006 Nov; 72(11):1477-84. PubMed ID: 16876765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage.
    Lin R; Lacoste J; Nakhaei P; Sun Q; Yang L; Paz S; Wilkinson P; Julkunen I; Vitour D; Meurs E; Hiscott J
    J Virol; 2006 Jun; 80(12):6072-83. PubMed ID: 16731946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MasterCARD: a priceless link to innate immunity.
    Hiscott J; Lin R; Nakhaei P; Paz S
    Trends Mol Med; 2006 Feb; 12(2):53-6. PubMed ID: 16406812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression.
    Kaukinen P; Sillanpää M; Kotenko S; Lin R; Hiscott J; Melén K; Julkunen I
    Virol J; 2006 Sep; 3():66. PubMed ID: 16945160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A wide range of NS3/4A protease catalytic efficiencies in HCV-infected individuals.
    Franco S; Clotet B; Martínez MA
    Virus Res; 2008 Feb; 131(2):260-70. PubMed ID: 18037183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS.
    Chen Z; Benureau Y; Rijnbrand R; Yi J; Wang T; Warter L; Lanford RE; Weinman SA; Lemon SM; Martin A; Li K
    J Virol; 2007 Jan; 81(2):964-76. PubMed ID: 17093192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-stranded RNA-induced interferon-beta and inflammatory cytokine production modulated by hepatitis C virus serine proteases derived from patients with hepatic diseases.
    Dansako H; Ikeda M; Ariumi Y; Wakita T; Kato N
    Arch Virol; 2009; 154(5):801-10. PubMed ID: 19353241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus NS3-4A inhibits the peroxisomal MAVS-dependent antiviral signalling response.
    Ferreira AR; Magalhães AC; Camões F; Gouveia A; Vieira M; Kagan JC; Ribeiro D
    J Cell Mol Med; 2016 Apr; 20(4):750-7. PubMed ID: 26865163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CARD games between virus and host get a new player.
    Johnson CL; Gale M
    Trends Immunol; 2006 Jan; 27(1):1-4. PubMed ID: 16309964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense.
    Johnson CL; Owen DM; Gale M
    J Biol Chem; 2007 Apr; 282(14):10792-803. PubMed ID: 17289677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of innate immune signaling and membrane targeting by the Hepatitis C virus NS3/4A protease are governed by the NS3 helix α0.
    Horner SM; Park HS; Gale M
    J Virol; 2012 Mar; 86(6):3112-20. PubMed ID: 22238314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
    Vazquez C; Tan CY; Horner SM
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic characterization of membrane-associated hepatitis C virus NS3-4A heterocomplex serine protease activity expressed in human cells.
    Hamill P; Jean F
    Biochemistry; 2005 May; 44(17):6586-96. PubMed ID: 15850392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepacivirus NS3/4A Proteases Interfere with MAVS Signaling in both Their Cognate Animal Hosts and Humans: Implications for Zoonotic Transmission.
    Anggakusuma ; Brown RJP; Banda DH; Todt D; Vieyres G; Steinmann E; Pietschmann T
    J Virol; 2016 Dec; 90(23):10670-10681. PubMed ID: 27654291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity.
    Li XD; Sun L; Seth RB; Pineda G; Chen ZJ
    Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17717-22. PubMed ID: 16301520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of Type I and III Interferon Response by Mitochondrial and Peroxisomal MAVS and Inhibition by Hepatitis C Virus.
    Bender S; Reuter A; Eberle F; Einhorn E; Binder M; Bartenschlager R
    PLoS Pathog; 2015 Nov; 11(11):e1005264. PubMed ID: 26588843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus variants resistant to macrocyclic NS3-4A inhibitors subvert IFN-β induction by efficient MAVS cleavage.
    Welsch C; Haselow K; Gouttenoire J; Schneider M; Morikawa K; Martinez Y; Susser S; Sarrazin C; Zeuzem S; Antes I; Moradpour D; Lange CM
    J Hepatol; 2015 Apr; 62(4):779-84. PubMed ID: 25463536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes.
    Ahlén G; Derk E; Weiland M; Jiao J; Rahbin N; Aleman S; Peterson DL; Pokrovskaja K; Grandér D; Frelin L; Sällberg M
    Gut; 2009 Apr; 58(4):560-9. PubMed ID: 18689426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct antiviral signaling pathways in primary human hepatocytes and their differential disruption by HCV NS3 protease.
    Jouan L; Melançon P; Rodrigue-Gervais IG; Raymond VA; Selliah S; Boucher G; Bilodeau M; Grandvaux N; Lamarre D
    J Hepatol; 2010 Feb; 52(2):167-75. PubMed ID: 20006398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cleavage of the T cell protein tyrosine phosphatase by the hepatitis C virus nonstructural 3/4A protease induces a Th1 to Th2 shift reversible by ribavirin therapy.
    Brenndörfer ED; Brass A; Karthe J; Ahlén G; Bode JG; Sällberg M
    J Immunol; 2014 Feb; 192(4):1671-80. PubMed ID: 24442435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.